Pediatrix Medical (MD) Equity Average (2010 - 2026)

Pediatrix Medical (MD) has 17 years of Equity Average data on file, last reported at $872.2 million in Q1 2026.

• Equity Average for Q1 2026 came in at $872.2 million, up 12.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $872.2 million (up 12.25% YoY), and the FY2025 annual result was $815.4 million, up 1.04% from the prior year.
• Equity Average eased to $872.2 million in Q1 2026 per MD's latest filing, from $878.3 million in the prior quarter.
• Over five years, Equity Average peaked at $955.2 million in Q3 2023 and troughed at $719.5 million in Q3 2024.
• A 5-year average of $851.1 million and a median of $862.2 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2024 and 2025: Equity Average slipped 24.68% in 2024, then rose 19.84% in 2025.
• A 5-year view of Equity Average shows it stood at $875.1 million in 2022, then increased by 3.81% to $908.5 million in 2023, then declined by 17.59% to $748.7 million in 2024, then advanced by 17.3% to $878.3 million in 2025, then fell by 0.69% to $872.2 million in 2026.
• Business Quant data shows MD's Equity Average at $872.2 million in Q1 2026, $878.3 million in Q4 2025, and $862.2 million in Q3 2025.